Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zingo for Venipuncture Pain in Chinese Children
NCT03653260Phase 3Completed
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- Aug 2018
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in venipuncture pain comparing Lidocaine (Zingo) with Placebo (2 arms). Primary endpoint: Wong-Baker FACES Pain Rating Scale After Venipuncture or Peripheral Cannulation. Started Aug 2018; status: completed.
02
Drugs
lidocaine
03
Conditions
venipuncture pain
Beyond the preview
Go deeper on NCT03653260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03653260.